Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic
liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted …

Context: Non-alcoholic fatty liver disease (NAFLD) is progressing considerably worldwide.
Identifying the risk factors of NAFLD is a critical step in preventing its progression. Methods …

Background. Nonalcoholic fatty liver disease (NAFLD) is commonly observed in patients
with type 2 diabetes (T2D). Semaglutide, a glucagon-like peptide 1 receptor agonist, may …

Background Oral semaglutide is the first glucagon-like peptide-1 receptor agonist (GLP-
1RA) designed for oral administration; it offers a promising opportunity to facilitate an early …

Background & Aims Dysmetabolic conditions could drive liver fibrosis in patients with non-
alcoholic fatty liver disease (NAFLD), increasing susceptibility to hepatocellular carcinoma …

Introduction Thyroid cancer incidence is increasing, and adiposity-related conditions are
gaining space in its pathogenesis. In this study, we aimed to detect any anthropometric …

Several investigations have revealed that COVID-19 causes a significant death rate due to
acute respiratory distress syndrome, alterations in the quantity of ACE2 receptor expression …

Non-alcoholic fatty liver disease (NAFLD), specifically liver steatosis and fibrosis with
steatohepatitis (NASH), is often associated with visceral adiposopathy, whose pathogenetic …

Adherence to the Mediterranean diet (MedDiet) leads to reduction of mortality from all
causes, especially in subjects with cardiovascular disease, obesity, and diabetes. Numerous …

Abstract Background and Aims Homocysteine (Hcy) levels are elevated in different
conditions, including cardiovascular diseases (CVD), diabetes, and metabolic-associated …